Trial Profile
efficacy of interferon-beta preceding sofosbuvir and ledipasvir combination therapy in genotype 1b HCV infected patients who failed to daclatasvir and asunaprevir therapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Jul 2018
Price :
$35
*
At a glance
- Drugs Interferon beta (Primary) ; Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 26 Jun 2018 Status changed from active, no longer recruiting to completed.
- 26 Feb 2018 Status changed from recruiting to active, no longer recruiting.
- 15 Sep 2015 New trial record